Serum and vitreous vascular endothelial growth factor levels in diabetic retinopathy

Sozen-Delil F. I., Cekic O., HAKLAR G.

INTERNATIONAL OPHTHALMOLOGY, cilt.43, sa.7, ss.2247-2255, 2023 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 43 Sayı: 7
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1007/s10792-022-02620-y
  • Dergi Adı: INTERNATIONAL OPHTHALMOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.2247-2255
  • Anahtar Kelimeler: Bevacizumab, Diabetic retinopathy, Ranibizumab, Triamcinolone acetonide, Vascular endothelial growth factor, Vitreous humor, INTRAVITREAL BEVACIZUMAB, INJECTION, FLUID, EYES
  • Marmara Üniversitesi Adresli: Evet

Özet

Purpose To research whether serum vascular endothelial growth factor (VEGF) levels could be used to evaluate diabetic retinopathy (DR) progression and to compare vitreous VEGF levels after injections of intravitreal bevacizumab (IVB), ranibizumab (IVR), and triamcinolone acetonide (IVTA) in proliferative diabetic retinopathy (PDR).